Cancer 360 brings patient data into one central system, so clinicians can prioritise those most in need and see patients quicker Millions of patients ...

Q1 2025 Earnings Call Transcript May 1, 2025 X4 Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $4.0E-5, ...

The success of fecal transplants to combat hospital-acquired diarrhea shows how crucial gut bacteria are to our bodies.

A research team at the Technical University of Munich (TUM) has developed a method to predict early-stage kidney damage ...

The Colorado legislature has seven days left in the 2025 session and is working Thursday to push legislation through ...

Q1 2025 Earnings Call Transcript April 29, 2025 Option Care Health, Inc. misses on earnings expectations. Reported EPS is ...

Regulus Therapeutics will be acquired by Novartis AG for $7 per share in cash. Click here for more information on RGLS ...

While chemotherapy, radiation and surgeries are common for most cancer treatments, immunotherapy is continuing to allow some ...

On the call from BioMarin management today are Alexander Hardy, President and Chief Executive Officer; Brian Mueller, Executive Vice President, Chief Financial Officer; Cristin Hubbard, Executive Vice ...

A trial shows that semaglutide stops fat accumulation and liver fibrosis in a disease associated with metabolic dysfunction ...

Nuo Therapeutics, Inc. (OTCQB: AURX) ("Nuo"), a commercial stage medical device company pioneering leading-edge biodynamic therapies by focusing on emerging ...

A research team at the Technical University of Munich (TUM) has developed a method to predict early-stage kidney damage ...